Lipocalin-2 and calprotectin as stool biomarkers for predicting necrotizing enterocolitis in premature neonates.

MLA

Thibault, Marie-Pier, et al. “Lipocalin-2 and Calprotectin as Stool Biomarkers for Predicting Necrotizing Enterocolitis in Premature Neonates.” Pediatric Research, vol. 91, no. 1, Jan. 2022, pp. 129–36. EBSCOhost, https://doi.org/10.1038/s41390-021-01680-7.

APA

Thibault, M.-P., Tremblay, É., Horth, C., Fournier-Morin, A., Grynspan, D., Babakissa, C., Levy, E., Ferretti, E., Bertelle, V., & Beaulieu, J.-F. (2022). Lipocalin-2 and calprotectin as stool biomarkers for predicting necrotizing enterocolitis in premature neonates. Pediatric Research, 91(1), 129–136. https://doi.org/10.1038/s41390-021-01680-7

Chicago

Thibault, Marie-Pier, Éric Tremblay, Chantal Horth, Aube Fournier-Morin, David Grynspan, Corentin Babakissa, Emile Levy, Emanuela Ferretti, Valérie Bertelle, and Jean-François Beaulieu. 2022. “Lipocalin-2 and Calprotectin as Stool Biomarkers for Predicting Necrotizing Enterocolitis in Premature Neonates.” Pediatric Research 91 (1): 129–36. doi:10.1038/s41390-021-01680-7.